What is it about?
We report a case of a patient with longstanding type 2 diabetes using multiple daily insulin injections who developed a rare subcutaneous tissue disorder from the injections. After this tissue was removed, she required much less insulin due to improved insulin absorption and action.
Featured Image
Read the Original
This page is a summary of: Impact of Insulin-Derived Amyloidosis on Glycemic Control and Insulin Dosing, Clinical Diabetes, July 2022, American Diabetes Association,
DOI: 10.2337/cd21-0118.
You can read the full text:
Contributors
Be the first to contribute to this page







